Skip to content

Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease

A Cross-sectional Observational Study, Based on Immunological and Ultrasonographic Evaluations, to Define the Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06324578
Enrollment
150
Registered
2024-03-22
Start date
2023-09-25
Completion date
2025-12-31
Last updated
2024-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Thyroid Disease, Sjögren

Keywords

Autoimmune Thyroiditis, Sjögren disease, Immune dysregulation disorders

Brief summary

The main study hypothesis is that Sjögren Disease (SD), usually considered a disorder typical of adult females, may occur not exceptionally in adolescence or even in childhood as a subclinical process. There are several pieces of evidence in favor of this hypothesis, from the incidental detection of asymptomatic SD in pediatric age to biobank-based studies showing that biological signs of SD may precede the disease clinical onset by years or decades. The best scenario to verify this hypothesis could be that of autoimmune thyroiditis, for the following three reasons: 1) subjects with Autoimmune thyroiditis (AT) have a high risk of developing SD (7%); 2) in cases with comorbidity of SD and AT the diagnosis of AT had usually been made before; 3) subjects with AT routinely undergo periodic blood examination and neck ultrasonography (US), which may include Salivary Gland Ultrasound (SGUS) providing contributive data to detect an asymptomatic pre-SD. The knowledge of the real association between AT and pre-SD may impact on several aspects of medicine.

Interventions

DIAGNOSTIC_TESTAT Testing

Analysis of blood specimens and neck ultrasonography

Sponsors

IRCCS Burlo Garofolo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
0 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Subjects between 0-17 years with autoimmune thyroiditis * Subjects between 0-17 years with previous diagnosis of SD or pre-SD

Exclusion criteria

* No informed consent from the patient's guardians * Active or recent infection within one week

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of pre-SD in pediatric subjects with ATAt the enrolment (T0)Pre-SD will be considered in cases with positive Anti-Sjögren's Syndrome A/Anti-Sjögren's Syndrome B antibodies and a positive Outcome Measures in Rheumatology (OMERACT) score at SGUS and/or a Focus score ≥1 at labial salivary gland (LSG) or parotid gland biopsy. Pre-SD definition meets the American college of rheumatology (ACR)/European league against rheumatism (EULAR) classification criteria for Sjogren Disease if symptoms suspicious of SD are present. Non-SD Sialadenitis is defined by a positive SGUS with negative SD related antibodies

Countries

Italy

Contacts

Primary ContactAlberto Tommasini, MD PhD Prof
alberto.tommasini@burlo.trieste.it+39.040.3785.422
Backup ContactBarbara Bonifacio
barbara.bonifacio@burlo.trieste.it+39.0403785.472

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026